OKYO Pharma’s (OKYO) “Buy” Rating Reaffirmed at HC Wainwright

OKYO Pharma (NASDAQ:OKYO)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They currently have a $7.00 target price on the stock.

OKYO Pharma Stock Up 2.8 %

Shares of OKYO opened at $1.10 on Tuesday. OKYO Pharma has a 1 year low of $0.81 and a 1 year high of $1.90. The stock has a 50 day simple moving average of $1.09 and a two-hundred day simple moving average of $1.07.

OKYO Pharma Company Profile

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.